Related Experiment Video

Updated: May 10, 2025

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging
08:14

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging

Published on: March 17, 2020

5.9K

Necroptosis: a significant and promising target for intervention of cardiovascular disease

Yan-Wei Ji1, Xin-Yu Wen1, He-Peng Tang1

  • 1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.

Biochemical Pharmacology
|April 23, 2025
PubMed

Insights

Necroptosis, a regulated cell death, is increasingly linked to cardiovascular diseases like heart failure and myocardial infarction. Understanding its pathways and inhibitors may reveal new therapeutic targets for these conditions.

Area of Science:

  • Cardiovascular Biology
  • Cell Death Mechanisms
  • Molecular Medicine

Background:

  • Cardiovascular diseases (CVDs) are a growing global health concern, driven by lifestyle changes and aging populations.
  • Cell death pathways, particularly necroptosis, are increasingly recognized as critical contributors to CVD development and progression.
  • Necroptosis is implicated in a wide range of cardiovascular conditions, including atherosclerosis, myocardial infarction, heart failure, and various cardiomyopathies.

Purpose of the Study:

  • To investigate the role of necroptosis in the pathogenesis of diverse cardiovascular diseases.
  • To identify key molecular players and inhibitors within necroptosis pathways relevant to cardiovascular conditions.
  • To explore potential therapeutic strategies targeting necroptosis for the treatment of cardiovascular diseases.

Main Methods:

  • Review and analysis of existing literature on necroptosis pathways and their involvement in cardiovascular diseases.
  • Examination of molecular mechanisms regulating necroptosis, including classical, CaMK, and mitochondria-dependent pathways.
  • Identification and analysis of inhibitors targeting key molecules in necroptosis.

Main Results:

  • Necroptosis is a significant factor in the pathophysiology of numerous cardiovascular diseases.
  • Specific molecular pathways and targets within necroptosis have been identified.
  • Inhibitors of necroptosis show potential for therapeutic intervention in cardiovascular disease models.

Conclusions:

  • Necroptosis represents a promising therapeutic target for a spectrum of cardiovascular diseases.
  • Further research into necroptosis modulation could lead to novel treatment strategies for conditions like heart failure and myocardial infarction.
  • Targeting necroptosis pathways offers a potential avenue to mitigate cardiovascular disease burden.

Keywords:
Cardiovascular diseaseCell deathMolecular pathwayNecroptosisTherapeutic targets

More Related Videos

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition08:38

Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition

Published on: July 21, 2023

1.1K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.0K

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.6K
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
5.6K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
9.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
2.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.1K